Cargando…

Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis

Anti-Wolbachia therapy delivers safe macrofilaricidal activity with superior therapeutic outcomes compared to all standard anti-filarial treatments, with the added benefit of substantial improvements in clinical pathology. These outcomes can be achieved, in principle, with existing registered drugs,...

Descripción completa

Detalles Bibliográficos
Autores principales:	TAYLOR, MARK J., HOERAUF, ACHIM, TOWNSON, SIMON, SLATKO, BARTON E., WARD, STEPHEN A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884836/ https://www.ncbi.nlm.nih.gov/pubmed/23866958 http://dx.doi.org/10.1017/S0031182013001108

Ejemplares similares

Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis
por: Johnston, Kelly L., et al.
Publicado: (2014)

A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis
por: Halliday, Alice, et al.
Publicado: (2014)

Boron-Pleuromutilins as Anti-Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis
por: Jacobs, Robert T., et al.
Publicado: (2019)

Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: Current perspectives
por: Wan Sulaiman, Wan Aliaa, et al.
Publicado: (2019)

Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis
por: Sharma, Raman, et al.
Publicado: (2016)

Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study
por: Hoerauf, Achim, et al.
Publicado: (2008)

Corrigendum: Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis
por: Sharma, Raman, et al.
Publicado: (2018)

Current perspective of new anti-Wolbachial and direct-acting macrofilaricidal drugs as treatment strategies for human filariasis
por: Ehrens, Alexandra, et al.
Publicado: (2022)

Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study
por: Hoerauf, Achim, et al.
Publicado: (2007)

Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis
por: Aljayyoussi, Ghaith, et al.
Publicado: (2017)

Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination
por: Alley, William Soumbey, et al.
Publicado: (2001)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin
por: Wilson, Nana O., et al.
Publicado: (2016)

Author Correction: Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis
por: Aljayyoussi, Ghaith, et al.
Publicado: (2018)

Elimination of lymphatic filariasis in South East Asia
por: Specht, Sabine, et al.
Publicado: (2019)

Wolbachia depletion blocks transmission of lymphatic filariasis by preventing chitinase-dependent parasite exsheathment
por: Quek, Shannon, et al.
Publicado: (2022)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso
por: Nikièma, Achille S., et al.
Publicado: (2021)

Repurposing Auranofin as a Lead Candidate for Treatment of Lymphatic Filariasis and Onchocerciasis
por: Bulman, Christina A., et al.
Publicado: (2015)

Therapeutic Efficacy and Macrofilaricidal Activity of Doxycycline for the Treatment of River Blindness
por: Walker, Martin, et al.
Publicado: (2015)

Review of Dancing Parasites in Lymphatic Filariasis
por: Dietrich, Christoph F., et al.
Publicado: (2019)

Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé Foci, Mali
por: Dolo, Housseini, et al.
Publicado: (2020)

The Wolbachia endosymbiont as an anti-filarial nematode target
por: Slatko, Barton E., et al.
Publicado: (2010)

Development of Pyrazolopyrimidine Anti-Wolbachia Agents for the Treatment of Filariasis
por: McGillan, Paul, et al.
Publicado: (2021)

Eliminating Lymphatic Filariasis, Onchocerciasis, and Schistosomiasis from the Americas: Breaking a Historical Legacy of Slavery
por: Lammie, Patrick J., et al.
Publicado: (2007)

Discovery of Substituted Di(pyridin-2-yl)-1,2,4-thiadiazol-5-amines as Novel Macrofilaricidal Compounds for the Treatment of Human Filarial Infections
por: Hawryluk, Natalie, et al.
Publicado: (2022)

Distinct N-Linked Immunoglobulin G Glycosylation Patterns Are Associated With Chronic Pathology and Asymptomatic Infections in Human Lymphatic Filariasis
por: Adjobimey, Tomabu, et al.
Publicado: (2022)

Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections
por: Schiefer, Andrea, et al.
Publicado: (2020)

Developing Eradication Investment Cases for Onchocerciasis, Lymphatic Filariasis, and Human African Trypanosomiasis: Rationale and Main Challenges
por: Tediosi, Fabrizio, et al.
Publicado: (2013)

Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitro
por: Hübner, Marc P., et al.
Publicado: (2020)

Wolbachia Lipoprotein Stimulates Innate and Adaptive Immunity through Toll-like Receptors 2 and 6 to Induce Disease Manifestations of Filariasis
por: Turner, Joseph D., et al.
Publicado: (2009)

Impact of Three Rounds of Mass Drug Administration on Lymphatic Filariasis in Areas Previously Treated for Onchocerciasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2013)

Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis
por: Kelly-Hope, Louise, et al.
Publicado: (2017)

Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes
por: Johnston, Kelly L, et al.
Publicado: (2010)

Doxycycline Reduces Plasma VEGF-C/sVEGFR-3 and Improves Pathology in Lymphatic Filariasis
por: Debrah, Alexander Yaw, et al.
Publicado: (2006)

Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides
por: Clare, Rachel H., et al.
Publicado: (2019)

AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis
por: Hong, W. David, et al.
Publicado: (2019)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa
por: Fischer, Peter U., et al.
Publicado: (2017)

Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d’Ivoire
por: Loukouri, Agodio, et al.
Publicado: (2020)

Integrated transmission assessment surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria
por: Anagbogu, Ifeoma N., et al.
Publicado: (2022)

Assessment of the burden of soil-transmitted helminthiasis after five years of mass drug administration for Onchocerciasis and Lymphatic filariasis in Kebbi State, Nigeria
por: Oluwole, Akinola Stephen, et al.
Publicado: (2017)

Status of Onchocerciasis Transmission after More Than a Decade of Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis Elimination in Central Nigeria: Challenges in Coordinating the Stop MDA Decision
por: Evans, Darin S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4he16p807kotg5ulfg637pqlff